TIAA CREF Investment Management’s Aimmune Therapeutics AIMT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.75M Sell
2018
Q4
$1.96M Sell
2018
Q3
$2.3M Sell
2018
Q2
$2.46M Buy
2018
Q1
$2.73M Buy
2017
Q4
$3.23M Sell
2017
Q3
$2.33M Sell
2017
Q2
$1.96M Buy
2017
Q1
$1.54M Sell
2016
Q4
$1.62M Sell
2016
Q3
$1.26K Sell
2016
Q2
$910K Buy
2016
Q1
$455K Sell
2015
Q4
$937K Buy
2015
Q3
$850K Buy